GENERIC NAME OF THE MEDICINAL PRODUCT:
2. Losartan Potassium And Hydrochlorothiazide Tablets IP 25mg+12.5mg (LOZART-H)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film-coated tablet contains:
Losartan Potassium IP…………………..50mg
Hydrochlorothiazide IP………………….12.5mg
Excipients……………………………………… q.s
Colour: Titanium Dioxide IP
2. Losartan Potassium And Hydrochlorothiazide Tablets IP 25mg+12.5mg
Each film-coated tablet contains:
Losartan Potassium IP…………………..25mg
Hydrochlorothiazide IP………………….12.5mg
Excipients……………………………………… q.s
Colour: Sunset yellow FCF
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
IT IS DANGEROUS TO TAKE THIS PREPARATION EXCEPT UNDER MEDICAL SUPERVISION.
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Protect from Light and moisture.
Dosage: As directed by the Physician
Losartan Potassium and Hydrochlorothiazide Tablets IP 25mg+12.5mg Technical Specification:
| Product Name: | Losartan Potassium and Hydrochlorothiazide Tablets IP |
| Brand Name: | LOZART-H |
| Strength: | (50mg+12.5mg), (25mg+12.5mg) |
| Dosage Form: | Tablets(film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihypertensive |
| Indication: | Losartan Potassium / Hydrochlorothiazide is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on losartan or hydrochlorothiazide alone. |
| Storage: | Store below 30°C. Protect from Light and moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
1. Losartan Potassium And Hydrochlorothiazide Tablets IP 50mg+12.5mg (LOZART-H)
2. Losartan Potassium And Hydrochlorothiazide Tablets IP 25mg+12.5mg (LOZART-H)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
1. Losartan Potassium And Hydrochlorothiazide Tablets IP 50mg+12.5mg
Each film-coated tablet contains:
Losartan Potassium IP…………………..50mg
Hydrochlorothiazide IP………………….12.5mg
Excipients……………………………………… q.s
Colour: Titanium Dioxide IP
2. Losartan Potassium And Hydrochlorothiazide Tablets IP 25mg+12.5mg
Each film-coated tablet contains:
Losartan Potassium IP…………………..25mg
Hydrochlorothiazide IP………………….12.5mg
Excipients……………………………………… q.s
Colour: Sunset yellow FCF
THERAPEUTIC INDICATIONS:
Losartan Potassium / Hydrochlorothiazide is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on losartan or hydrochlorothiazide alone.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
IT IS DANGEROUS TO TAKE THIS PREPARATION EXCEPT UNDER MEDICAL SUPERVISION.
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Storage: Store below 30°C.
Protect from Light and moisture.
Dosage: As directed by the Physician.
